<DOC>
	<DOCNO>NCT02100462</DOCNO>
	<brief_summary>This randomize , double-blinded , three-period crossover study platelet activation aggregation 30 non-smoking healthy volunteer compare chlorthalidone ( CTD ) , hydrochlorothiazide ( HCTZ ) , aspirin ( ASA ; active control ) . The study hypothesis CTD different effect platelet activation aggregation HCTZ .</brief_summary>
	<brief_title>Chlorthalidone HCTZ Impacts Platelet Activation</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Men woman age 19 old Not currently take routinely schedule prescription counter medication herbal supplement No use aspirin , clopidogrel , prasugrel , ticagrelor , cilostazol , dipyridamole , NSAID medication , herbal supplement within previous 7 day able refrain use study period Systolic blood pressure &gt; 110 mmHg diastolic blood pressure &gt; 60 mmHg Nonsmoker Previous adverse reaction allergy HCTZ , CTD , ASA Severe sulfonamide hypersensitivity ( anaphylaxis StevensJohnson syndrome ) Diagnosis chronic disease condition History gout hyperuricemia History pancreatitis History systemic lupus erythematosus ( SLE ) History hypokalemia require treatment Pregnant planning become pregnant study period Breastfeeding History hypotension History gastrointestinal bleeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Platelet activation</keyword>
	<keyword>Platelet aggregation</keyword>
	<keyword>Chlorthalidone</keyword>
</DOC>